Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 4
1959 1
1961 1
1962 2
1964 2
1971 2
1974 1
1975 1
1979 1
1982 1
1984 1
1985 1
1986 4
1987 1
1988 1
1989 2
1990 6
1991 1
1992 4
1993 1
1994 7
1995 3
1996 3
1997 4
1998 10
1999 12
2000 11
2001 14
2002 21
2003 20
2004 36
2005 51
2006 48
2007 62
2008 77
2009 94
2010 108
2011 116
2012 141
2013 157
2014 160
2015 166
2016 166
2017 178
2018 194
2019 214
2020 228
2021 297
2022 336
2023 311
2024 194

Text availability

Article attribute

Article type

Publication date

Search Results

3,101 results

Results by year

Filters applied: . Clear all
Page 1
R-loop-dependent promoter-proximal termination ensures genome stability.
Xu C, Li C, Chen J, Xiong Y, Qiao Z, Fan P, Li C, Ma S, Liu J, Song A, Tao B, Xu T, Xu W, Chi Y, Xue J, Wang P, Ye D, Gu H, Zhang P, Wang Q, Xiao R, Cheng J, Zheng H, Yu X, Zhang Z, Wu J, Liang K, Liu YJ, Lu H, Chen FX. Xu C, et al. Among authors: chi y. Nature. 2023 Sep;621(7979):610-619. doi: 10.1038/s41586-023-06515-5. Epub 2023 Aug 9. Nature. 2023. PMID: 37557913 Free PMC article.
Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1.
Gao Y, Chi Y, Chen Y, Wang W, Li H, Zheng W, Zhu P, An J, Duan Y, Sun T, Liu X, Xue F, Liu W, Fu R, Han Z, Zhang Y, Yang R, Cheng T, Wei J, Zhang L, Zhang X. Gao Y, et al. Among authors: chi y. Nat Commun. 2023 Jul 20;14(1):4373. doi: 10.1038/s41467-023-39958-5. Nat Commun. 2023. PMID: 37474525 Free PMC article.
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.
Goldsmith KC, Park JR, Kayser K, Malvar J, Chi YY, Groshen SG, Villablanca JG, Krytska K, Lai LM, Acharya PT, Goodarzian F, Pawel B, Shimada H, Ghazarian S, States L, Marshall L, Chesler L, Granger M, Desai AV, Mody R, Morgenstern DA, Shusterman S, Macy ME, Pinto N, Schleiermacher G, Vo K, Thurm HC, Chen J, Liyanage M, Peltz G, Matthay KK, Berko ER, Maris JM, Marachelian A, Mossé YP. Goldsmith KC, et al. Among authors: chi yy. Nat Med. 2023 May;29(5):1092-1102. doi: 10.1038/s41591-023-02297-5. Epub 2023 Apr 3. Nat Med. 2023. PMID: 37012551 Free PMC article. Clinical Trial.
Imaging diagnosis in peripheral nerve injury.
Dong Y, Alhaskawi A, Zhou H, Zou X, Liu Z, Ezzi SHA, Kota VG, Abdulla MHAH, Olga A, Abdalbary SA, Chi Y, Lu H. Dong Y, et al. Among authors: chi y. Front Neurol. 2023 Sep 14;14:1250808. doi: 10.3389/fneur.2023.1250808. eCollection 2023. Front Neurol. 2023. PMID: 37780718 Free PMC article. Review.
3,101 results